Clovis Oncology Inc (NASDAQ:CLVS) announced that five abstracts highlighting clinical progress and results from Phase 1 and 2 studies of the company’s three compounds will be presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. Clovis Oncology Inc (NASDAQ:CLVS) stock opened today at $55.11 and is currently trading at $57.81. The stock showed a positive weekly performance of 0.39%.
Northwest Biotherapeutics, Inc (NASDAQ:NWBO) provided an initial patient case study, showing signs of tumor necrosis (tumor death) and initial tumor regression, from the Company’s ongoing DCVax-Direct trial for all types of inoperable solid tumors. The Company plans to announce further case study information prior to the annual ASCO conference, while it continues collecting data from the trial. Although the trial is still at an early stage, with many of the patients only part way through the treatment regimen, the Company also plans to provide overall information about the data to date by the time of the ASCO conference. Northwest Biotherapeutics, Inc (NASDAQ:NWBO) stock opened at $6.70, in current trading session and currently is at $6.08, by gaining 2.36%. The 52 week range of $3.10 – $10.64. Company’s market capitalization is $338.87 billion.
E Commerce China Dangdang Inc (ADR) (NYSE:DANG)sees Q2 revenue up 30% to around RMB 1.94B. The company also expects GMV from its marketplace to grow at a rate of 80% year-over-year in Q2. E Commerce China Dangdang Inc (ADR) (NYSE:DANG) stock is currently trading at $9.74. The EPS of the stock is -0.29. Company’s market capitalization is $783.77 million.
Wal-Mart Stores, Inc. (NYSE:WMT) moved closer to supporting an increase in the federal minimum wage, reversing course from its previous promise to stay neutral in the nationwide debate over moving past the $7.25-an-hour minimum. Wal-Mart Stores, Inc. (NYSE:WMT) stock opened the session at $76.28, and now is at $77.08. The 52 week range of the WMT stock remained $71.51 – $81.37 and the day range was $76.25 – $77.44.
Kindred Healthcare Inc. on Thursday made public a $533 million takeover bid for home health and hospice company Gentiva Health Services, Inc. (NASDAQ:GTIV) that it said was rebuffed. A representative from Gentiva, which provides skilled nursing, physical, occupational, speech and neuro rehabilitation therapies, wasn’t immediately available for comment. Gentiva Health Services, Inc. (NASDAQ:GTIV) stock opened at $13.90, in current trading session and currently is at $13.97, by gaining 63.21%. The 52 week range of $7.35 – $14.50. Company’s market capitalization is $515.04 million.